NGEx Minerals Ltd. is pleased to announce the election of Mr. Alessandro Bitelli to the Company's Board of Directors at the Annual General and Special Meeting of Shareholders held on 27, 2023. View PDF version Mr. Bitelli brings extensive expertise. - Veroeffentlicht am 29.06.2023
AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, announced today that on May 17, 2023 it received a notice from the staff of the NYSE. | May 23, 2023
NGEx Minerals Ltd. is pleased to report its results for the three months ended March 31, 2023. PDF version Wojtek Wodzicki, President and CEO commented, "NGEx has continued its strong performance to start 2023, with exceptional exploration results. - Veroeffentlicht am 16.05.2023
AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023.
Balance. | May 12, 2023